Labcorp Holdings INC Form 4 insider transactions

Labcorp's EVP, CIO & CTO, Akinbolade Oyegunwa, exercised restricted stock units and sold a portion of the resulting shares to cover tax obligations.

Labcorp's EVP of Operations, Jonathan C. Meltzer, reported the vesting of restricted stock units and subsequent sale of shares, including for tax obligations and under a 10b5-1 plan.

Labcorp's EVP, Chief Legal Officer, Kathryn W. Kyle, reported the vesting and tax-related disposition of company stock and Restricted Stock Units.

Labcorp's EVP, CHRO, Anita Z. Graham, converted 356 Restricted Stock Units into common stock and subsequently sold 109 shares to cover tax obligations.

Labcorp Holdings Inc. EVP Brian J. Caveney reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations.

Labcorp's EVP, President of Central Labs & International, Megan D. Bailey, exercised restricted stock units and sold a portion of the resulting common stock to cover tax obligations.

Labcorp Holdings Inc. Director Paul Rothman converted 897 Restricted Stock Units into common stock on February 11, 2026, increasing his direct holdings to 2,571 shares.

Labcorp Holdings Inc. Director Kathryn E. Wengel converted 897 Restricted Stock Units into common stock on February 11, 2026.

Labcorp Holdings Inc. Director Richelle P. Parham acquired 897 shares of common stock through the vesting of Restricted Stock Units on February 11, 2026.

Labcorp Holdings Inc. Director Peter M. Neupert converted 897 Restricted Stock Units into common stock on February 11, 2026, increasing his direct common stock holdings.

Labcorp Holdings Inc. Director Garheng Kong acquired 897 shares of common stock following the vesting of Restricted Stock Units on February 11, 2026.

Labcorp Holdings Inc. Director Kirsten Kliphouse converted 897 Restricted Stock Units into common stock on February 11, 2026, increasing her direct holdings.

Jeffrey A. Davis, a Director at Labcorp Holdings Inc., converted 897 Restricted Stock Units into common stock on February 11, 2026.

Labcorp Holdings Inc. Director Kerrii B. Anderson converted 897 Restricted Stock Units into common stock on February 11, 2026.

Labcorp Holdings Inc. CEO Adam H. Schechter was granted 31,700 non-qualified stock options and 10,440 restricted stock units on February 10, 2026.

Labcorp's EVP of Operations, Jonathan C. Meltzer, reported a sale of common stock and the acquisition of new stock options and restricted stock units.

Labcorp Holdings Inc.'s EVP and Chief Legal Officer, Kathryn W. Kyle, was granted 2,700 non-qualified stock options and 880 restricted stock units on February 10, 2026.

Labcorp Holdings Inc. EVP Bryan T. Vaughn received 2,200 non-qualified stock options and 730 restricted stock units on February 10, 2026, as part of the company's incentive plan.

Labcorp Holdings Inc.'s Chief Financial Officer, Julia Aijun Wang, was granted 7,100 non-qualified stock options and 2,350 restricted stock units on February 10, 2026.

Labcorp Holdings Inc.'s SVP and Chief Accounting Officer, Peter J. Wilkinson, was granted 1,300 non-qualified stock options and 440 restricted stock units.

Labcorp Holdings Inc. EVP, CIO & CTO Akinbolade Oyegunwa received 2,400 non-qualified stock options and 810 restricted stock units on February 10, 2026.

Labcorp Holdings Inc.'s EVP, Chief Marketing Officer, Amy B. Summy, was granted non-qualified stock options and restricted stock units on February 10, 2026.

Labcorp's Executive Vice President and Chief Human Resources Officer, Anita Z. Graham, acquired 4,100 non-qualified stock options and 1,360 restricted stock units.

Labcorp Holdings Inc. EVP Megan D. Bailey received grants of non-qualified stock options and restricted stock units on February 10, 2026, aligning her interests with shareholder value.

Labcorp's EVP, Brian J. Caveney, increased his equity stake by acquiring 6,100 non-qualified stock options and 2,020 restricted stock units on February 10, 2026.

Labcorp Holdings Inc. Director Garheng Kong acquired 773 Restricted Stock Units, vesting on February 10, 2027, increasing his total beneficial ownership to 1,670 RSUs.

Labcorp Holdings Inc. Director Paul Rothman reported the acquisition of 733 Restricted Stock Units, increasing his beneficial ownership to 1,670 units.

Labcorp Holdings Inc. Director John H. Sampson was granted 773 Restricted Stock Units, aligning his interests with shareholders.

Labcorp Holdings Inc. Director Kathryn E. Wengel reported the acquisition of 773 Restricted Stock Units, vesting in 2027.

Labcorp Holdings Inc. Director Richelle P. Parham was granted 773 Restricted Stock Units, aligning her interests with shareholders.